Letters |

Androgen Deprivation Therapy for Prostate Cancer and Cardiovascular Death

Robert P. Blankfield, MD, MS
JAMA. 2012;307(12):1252-1253. doi:10.1001/jama.2012.352.
Text Size: A A A
Published online


To the Editor: The validity of the results of the meta-analysis by Dr Nguyen and colleagues1 regarding an association between androgen deprivation therapy (ADT) and cardiovascular death in patients with prostate cancer is suspect because the 8 studies that met the inclusion criteria may be biased. Androgen deprivation therapy was administered for a time interval that was less than the duration of data collection in 6 of the 8 studies, thereby introducing timing bias. In these 6 studies, ADT was administered for a period ranging from 3 months to 5.1 years, whereas the median duration of data collection in these studies ranged from 7.6 to 13 years. Because the time interval of ADT administration differs from the time interval of data collection in these studies, it is problematic to use them to test whether there is an association between ADT and cardiovascular death.


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




March 28, 2007
Andrew T. Yan, MD; Raymond T. Yan, MD; Shaun G. Goodman, MD, MSc
JAMA. 2007;297(12):1313-1315. doi:10.1001/jama.297.12.1313-b.
March 28, 2012
Paul L. Nguyen, MD; Youjin Je, MS; Toni K. Choueiri, MD
JAMA. 2012;307(12):1252-1253. doi:10.1001/jama.2012.353.
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.